97582-36-0Relevant academic research and scientific papers
BENZYLIDENE RHODANINES
-
, (2008/06/13)
This invention provides novel benzylidene rhodanines which are useful as agents in treating or preventing conditions associated with . beta.-amyloid peptide. This invention further provides methods of treating or preventing Alzheimer's Disease which comprises administering to a mammal in need thereof an effective amount of one or more of the benzylidene rhodanines of the present invention.
Leukotriene antagonist intermediates
-
, (2008/06/13)
This invention provides novel benzene derivatives which are leukotriene antagonists, formulations of those derivatives, intermediates for preparing the derivatives, and a method of using those derivatives for the treatment of conditions characterized by a
Thiadizazole compounds as antagonists of SRS-A
-
, (2008/06/13)
This invention relates to novel heterocyclic compounds structurally characterized by containing a specific heterocyclic group and by the presence of --CH2 --S-- directly bound to the specific heterocyclic group. These heterocyclic compounds are useful as medicines, particularly as antagonists of SRS-A (slow reacting substance of anaphylaxis).
Leukotriene Receptor Antagonists. 2. The methyl>acetophenone Derivatives
Dillard, Robert D.,Carr, F. Patrick,McCullough, Doris,Haisch, Klaus D.,Rinkema, Lynn E.,Fleisch, Jerome H.
, p. 911 - 918 (2007/10/02)
A series of methyl>acetophenones was synthesized and evaluated as antagonists of leukotriene D4 induced contractions of guinea pig ileum.Substitution at the 3-position of the acetophenone with ethyl (66), propyl (68), b
